Innogenetics achieves CE mark for new human papillomavirus (HPV) genotyping test

04-Jun-2008

Innogenetics announced that it has received CE marking for its new and expanded HPV genotyping test, the INNO-LiPA HPV Genotyping Extra. The new generation kit allows the genotyping of 28 different HPV genotypes, of which 18 are high-risk types for the possible development of cervical cancer. The test is based on Innogenetics' patent-protected SPF10 primers.

The INNO-LiPA HPV Genotyping Extra is designed for the identification of 28 different genotypes. The test encompasses 18 high-risk genotypes, including genotypes 16, and 18; 7 low-risk genotypes, including genotypes 6 and 11; and 3 additional genotypes. The useful information provided by the INNO-LiPA HPV Genotyping Extra can thereby serve as an important complement to Pap smear testing, and current DNA-based HPV screening tests. Automation is available, allowing the simultaneous processing of up to 48 different patient samples. Results are available within 3 hours.

Innogenetics will initially commercialize the product throughout Europe, where the product will be sold through its own specialized sales force. The INNO-LiPA HPV Genotyping Extra kit is anticipated to add to Innogenetics' revenues as of this quarter.

Other news from the department research and development

Most read news

More news from our other portals

Under the magnifying glass: The world of microscopy